ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Idaho » Internal Medicine

Top Internal Medicine Prescribers in Idaho

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SUSAN BAXTER MD

Internal Medicine

7,397

$477K

442
352 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $58

JOEL SWANSON MD

Internal Medicine

7,395

$509K

510
446 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$69
Average prescription price

Avg: $58

SUSAN BLOUGH M.D.

Internal Medicine

7,368

$379K

379
341 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $58

JAMES PATAKY MD

Internal Medicine

7,318

$351K

355
326 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $58

LOUIS SCHLICKMAN M.D.

Internal Medicine

7,309

$448K

445
395 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $58

SHANE ANDERSON D.O.

Internal Medicine

7,301

$377K

299
248 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $58

SCOTT TAYLOR M.D.

Internal Medicine

7,162

$330K

498
439 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $58

LESLIE STUBBS M.D.

Internal Medicine

7,108

$487K

421
355 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $58

SUSAN DAUGHARTY FOWLER MD

Internal Medicine

7,078

$428K

329
290 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $58

JEFFREY DZIECZKOWSKI MD

Internal Medicine

7,006

$392K

425
389 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $58

CHARLA WILLIS MD

Internal Medicine

6,950

$393K

399
324 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $58

DAVID LEE MD

Internal Medicine

6,926

$400K

398
313 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $58

FRANK JOHNSON M.D.

Internal Medicine

6,616

$358K

500
441 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $58

DAVID NIELSEN MD

Internal Medicine

6,511

$409K

377
332 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $58

TIMOTHY DYKSTRA DO

Internal Medicine

6,382

$507K

330
267 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$79
Average prescription price

Avg: $58

EDWARD THOMPSON MD

Internal Medicine

6,245

$380K

366
298 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $58

NATASHA MILTNER MD

Internal Medicine

6,075

$316K

448
392 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $58

STEPHEN DENAGY M4915

Internal Medicine

6,009

$929K

231
40 are 65+

19%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 14%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$155
Average prescription price

Avg: $58

MICHAEL CARRAHER MD

Internal Medicine

5,919

$359K

222
155 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

33%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $58

ERIKA LEWIS M.D.

Internal Medicine

5,815

$278K

294
241 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $58

MICHAEL HEDEMARK MD

Internal Medicine

5,669

$334K

468
424 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $58

MICHAEL KOELSCH M.D.

Internal Medicine

5,651

$302K

230
192 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $58

ROBERT GILBERT MD

Internal Medicine

5,578

$407K

302
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$73
Average prescription price

Avg: $58

MICHAEL PELTON M.D.

Internal Medicine

5,314

$360K

358
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $58

CORWIN GROOM MD

Internal Medicine

5,243

$304K

267
217 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

28%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank